Get the Stockscreener App
37.45
3.43%
-1.33
After Hours:
37.45
Harmony Biosciences Holdings Inc Stock (HRMY) Forecast
The Harmony Biosciences Holdings Inc (HRMY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $27.52, representing a -26.53% decrease from the current price of $37.45. The highest analyst price target is $29.39, and the lowest is $25.65.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HRMY Price Target
Average 34.22
(-8.62% Downside)
Is Harmony Biosciences Holdings Inc (HRMY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.86 | Neutral |
| STOCH(9,6) | 53.44 | Neutral |
| STOCHRSI(14) | 22.37 | Neutral |
| MACD(12,26) | 0.8748 | Sell |
| ADX(14) | 22.76 | Neutral |
| William %R | -75.24 | Neutral |
| CCI(14) | -45.48 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
38.71
Sell
|
38.49
Sell
|
| MA20 |
38.17
Sell
|
37.91
Sell
|
| MA50 |
35.73
Buy
|
36.53
Buy
|
| MA100 |
35.63
Buy
|
35.59
Buy
|
| MA200 |
33.96
Buy
|
34.31
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, HRMY could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on HRMY, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 49.86 indicates that HRMY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.44 indicates that HRMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 22.37 indicates that HRMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.76 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -45.48 indicates that HRMY is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HRMY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Harmony Biosciences Holdings Inc financial reports and earnings history, Harmony Biosciences Holdings Inc (HRMY) stock could reach $36.53 by 2030, $19.17 by 2040 and $7.0759 by 2050. See the projected annual prices until 2050 of the Harmony Biosciences Holdings Inc stock below:
- Harmony Biosciences Holdings Inc (HRMY) is expected to reach an average price of $28.83 in 2035, with a high prediction of $34.81 and a low estimate of $28.22. This indicates an $-23.01% rise from the last recorded price of $37.45.
- Harmony Biosciences Holdings Inc (HRMY) stock is projected to chart a bullish course in 2040, with an average price target of $17.53, representing an $-53.20% surge from its current level. The forecast ranges from a conservative $16.16 to a sky-high $19.17.
- Our analysts predict Harmony Biosciences Holdings Inc (HRMY) to jump -66.91% by 2045, soaring from $8.6959 to an average price of $12.39, potentially reaching $13.98. While $8.6959 is the low estimate, the potential upside is significant.
- Harmony Biosciences Holdings Inc (HRMY) stock is expected to climb by 2050, reaching an average of $3.618, a $-90.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.0759 and $0.552, respectively, highlighting the market's uncertainty.
Harmony Biosciences Holdings Inc Stock (HRMY) Year by Year Forecast
Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2025
Harmony Biosciences Holdings Inc Stock (HRMY) is expected to reach an average price of $30.77 in 2025, with a high prediction of $41.21 and a low estimate of $20.33. This indicates an -17.84% fall from the last recorded price of $37.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $26.53 | $25.65 | $29.39 | -29.17% |
| April, 2025 | $23.28 | $22.70 | $27.28 | -37.83% |
| May, 2025 | $27.39 | $20.33 | $27.57 | -26.85% |
| June, 2025 | $31.41 | $25.92 | $32.48 | -16.14% |
| July, 2025 | $33.58 | $30.64 | $34.98 | -10.33% |
| August, 2025 | $36.80 | $30.35 | $39.57 | -1.72% |
| September, 2025 | $32.85 | $31.51 | $39.68 | -12.29% |
| October, 2025 | $39.21 | $29.06 | $39.57 | +4.71% |
| November, 2025 | $29.07 | $28.94 | $41.21 | -22.39% |
| December, 2025 | $33.76 | $26.87 | $35.59 | -9.85% |
Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2026
The predicted value for Harmony Biosciences Holdings Inc (HRMY) in 2026 is set at an average of $43.00. Estimates vary from a peak of $57.58 to a trough of $28.43, indicating an +14.83% surge from the present price of $37.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $39.21 | $29.79 | $41.99 | +4.71% |
| February, 2026 | $45.35 | $36.63 | $48.11 | +21.09% |
| March, 2026 | $40.42 | $40.16 | $49.38 | +7.93% |
| April, 2026 | $38.99 | $28.43 | $41.16 | +4.12% |
| May, 2026 | $47.08 | $36.54 | $48.23 | +25.71% |
| June, 2026 | $49.07 | $43.87 | $52.55 | +31.03% |
| July, 2026 | $42.52 | $40.62 | $52.02 | +13.53% |
| August, 2026 | $42.46 | $38.70 | $43.91 | +13.37% |
| September, 2026 | $46.53 | $37.29 | $47.13 | +24.26% |
| October, 2026 | $54.33 | $43.30 | $56.14 | +45.06% |
| November, 2026 | $55.26 | $48.54 | $57.03 | +47.55% |
| December, 2026 | $50.61 | $49.28 | $57.58 | +35.13% |
Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Harmony Biosciences Holdings Inc (HRMY) is $32.68, with a high forecast of $51.11 and a low forecast of $14.26. This indicates an -12.72% decrease from the last price of $37.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $44.09 | $38.63 | $51.11 | +17.72% |
| February, 2027 | $44.80 | $41.77 | $45.94 | +19.63% |
| March, 2027 | $37.47 | $35.07 | $46.28 | +0.04% |
| April, 2027 | $27.07 | $25.36 | $40.72 | -27.72% |
| May, 2027 | $31.70 | $26.72 | $33.00 | -15.35% |
| June, 2027 | $30.55 | $29.40 | $32.43 | -18.43% |
| July, 2027 | $29.03 | $28.73 | $33.13 | -22.48% |
| August, 2027 | $30.98 | $28.64 | $33.17 | -17.27% |
| September, 2027 | $31.88 | $27.12 | $33.49 | -14.88% |
| October, 2027 | $31.92 | $28.48 | $34.90 | -14.76% |
| November, 2027 | $15.78 | $14.26 | $30.47 | -57.86% |
| December, 2027 | $22.64 | $14.45 | $22.94 | -39.55% |
Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2028
In 2028, Harmony Biosciences Holdings Inc (HRMY) is projected to reach an average price of $31.06, with a high projection of $42.96 and a low estimate of $19.16. This indicates an -17.07% fall from the last price of $37.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $26.68 | $22.78 | $28.71 | -28.75% |
| February, 2028 | $27.67 | $24.70 | $30.19 | -26.10% |
| March, 2028 | $26.88 | $26.09 | $29.06 | -28.22% |
| April, 2028 | $27.82 | $25.23 | $31.11 | -25.71% |
| May, 2028 | $29.32 | $25.08 | $30.18 | -21.71% |
| June, 2028 | $25.07 | $23.89 | $29.82 | -33.05% |
| July, 2028 | $25.57 | $22.02 | $30.15 | -31.73% |
| August, 2028 | $24.06 | $20.28 | $37.53 | -35.76% |
| September, 2028 | $30.76 | $19.16 | $31.29 | -17.87% |
| October, 2028 | $33.89 | $27.42 | $42.96 | -9.51% |
| November, 2028 | $25.91 | $25.47 | $42.94 | -30.81% |
| December, 2028 | $29.11 | $24.87 | $30.60 | -22.28% |
Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2029
The 2029 price forecast for Harmony Biosciences Holdings Inc Stock (HRMY) is $25.26 on average, with a high prediction of $34.97 and a low estimate of $15.56. This represents an -32.54% decrease from the previous price of $37.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $27.83 | $23.66 | $31.30 | -25.70% |
| February, 2029 | $21.70 | $19.89 | $29.28 | -42.05% |
| March, 2029 | $18.69 | $16.86 | $24.33 | -50.10% |
| April, 2029 | $18.11 | $17.16 | $20.69 | -51.64% |
| May, 2029 | $22.41 | $15.86 | $24.81 | -40.15% |
| June, 2029 | $20.21 | $18.35 | $22.76 | -46.04% |
| July, 2029 | $16.63 | $15.56 | $20.85 | -55.58% |
| August, 2029 | $24.40 | $16.42 | $27.74 | -34.86% |
| September, 2029 | $28.17 | $23.41 | $30.24 | -24.78% |
| October, 2029 | $31.39 | $25.63 | $34.85 | -16.17% |
| November, 2029 | $29.35 | $28.69 | $34.97 | -21.63% |
| December, 2029 | $28.75 | $24.36 | $30.99 | -23.22% |
Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2030
Harmony Biosciences Holdings Inc Stock (HRMY) is expected to reach an average price of $35.08 in 2030, with a high forecast of $47.96 and a low forecast of $22.20. This signifies an -6.33% decrease from the last price of $37.45.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.32 | $25.92 | $36.53 | -27.04% |
| February, 2030 | $28.78 | $22.20 | $29.37 | -23.15% |
| March, 2030 | $30.65 | $25.14 | $31.84 | -18.14% |
| April, 2030 | $41.85 | $28.73 | $42.61 | +11.75% |
| May, 2030 | $41.72 | $37.54 | $44.75 | +11.41% |
| June, 2030 | $32.11 | $23.81 | $41.88 | -14.27% |
| July, 2030 | $34.79 | $30.70 | $37.91 | -7.11% |
| August, 2030 | $45.58 | $34.66 | $47.96 | +21.72% |
| September, 2030 | $43.36 | $39.70 | $47.45 | +15.78% |
| October, 2030 | $35.25 | $34.15 | $45.85 | -5.87% |
| November, 2030 | $35.21 | $32.75 | $39.36 | -5.99% |
| December, 2030 | $43.32 | $34.60 | $44.27 | +15.68% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):